{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:47:14Z","timestamp":1777081634755,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jpsychires.2013.05.029","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T10:30:46Z","timestamp":1371897046000},"page":"1337-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients"],"prefix":"10.1016","volume":"47","author":[{"given":"Marlijn","family":"Vermeiden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter W.","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A.","family":"Bruijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom K.","family":"Birkenh\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2013.05.029_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I","article-title":"SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability","volume":"7","author":"Anderson","year":"1998","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hup.470080605","article-title":"Severity of depression and benzodiazepine co-medication in relationship to efficacy of antidepressants in acute trials","volume":"8","author":"Angst","year":"1993","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3956(96)00029-5","article-title":"A\u00a0randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia","volume":"30","author":"Benkert","year":"1996","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00213-005-0098-0","article-title":"Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?","volume":"181","author":"Birkenh\u00e4ger","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246131","article-title":"A\u00a0double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients","volume":"127","author":"Bruijn","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib7","series-title":"Structured clinical interview for DSM-IV axis I disorders","author":"First","year":"1999"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00228-003-0710-3","article-title":"Time course of clinical response to venlafaxine: relevance of plasma level and chirality","volume":"59","author":"Gex-Fabry","year":"2004","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/0269881104042621","article-title":"Tolerability of high-dose venlafaxine in depressed patients","volume":"18","author":"Harrison","year":"2004","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.57.5.503","article-title":"Evidence of the dual mechanisms of action of venlafaxine","volume":"57","author":"Harvey","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0447.1997.tb10136.x","article-title":"Efficacy of venlafaxine in depressive illness in general practice","volume":"95","author":"Lecrubier","year":"1997","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib13","first-page":"41","article-title":"Factors that influence the outcome of placebo-controlled antidepressant clinical trials","volume":"33","author":"Niklson","year":"1997","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00004714-199408000-00002","article-title":"Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response","volume":"14","author":"Perry","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199108293250907","article-title":"The pharmacologic treatment of depression","volume":"325","author":"Potter","year":"1991","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0193-953X(18)30167-9","article-title":"Therapeutic drug monitoring. Principles and practice","volume":"16","author":"Preskorn","year":"1993","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.7244645","article-title":"Medical therapies for mood disorders alter the blood-brain barrier","volume":"213","author":"Preskorn","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4088\/JCP.v59n0305","article-title":"A\u00a0randomized placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression","volume":"59","author":"Rudolph","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib19","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0006-3223(02)01425-7","article-title":"Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression","volume":"52","author":"Stahl","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib20","first-page":"104","article-title":"Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients","volume":"55","author":"Schweizer","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-004-1853-3","article-title":"A\u00a0double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients","volume":"175","author":"van den Broek","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0269881108089821","article-title":"Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis","volume":"23","author":"van den Broek","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2013.05.029_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0447.2009.01464.x","article-title":"Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine","volume":"121","author":"Wijkstra","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"}],"updated-by":[{"DOI":"10.1016\/j.jpsychires.2015.07.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000}}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395613001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395613001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:09:08Z","timestamp":1758366548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395613001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0022395613001787"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2013.05.029","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2013.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}